Structures by: Ouazzani Chahdi F. O.
Total: 16
(Pyridin-2-yl)methyl 6-bromo-2-oxo-1-[(pyridin-2-yl)methyl]-1,2-dihydroquinoline-4-carboxylate
C22H16BrN3O3
IUCrData (2018) 3, 2 x180288
a=34.0146(11)Å b=4.9522(2)Å c=23.4539(7)Å
α=90° β=111.5780(10)° γ=90°
(Pyridin-2-yl)methyl 2-oxo-1-[(pyridin-2-yl)methyl]-1,2-dihydroquinoline-4-carboxylate hemihydrate
C22H17N3O3,0.5(H2O)
IUCrData (2017) 2, 7 x171038
a=4.96340(10)Å b=14.0708(3)Å c=25.7168(6)Å
α=90° β=90.6020(10)° γ=90°
7-Bromo-1,4-dibutyl-1,2,3,4-tetrahydropyrido[2,3-<i>b</i>]pyrazine-2,3-dione
C15H20BrN3O2
IUCrData (2017) 2, 7 x170984
a=22.569(6)Å b=5.1097(13)Å c=13.497(3)Å
α=90° β=90° γ=90°
1,4,6-Trimethylquinoxaline-2,3(1<i>H</i>,4<i>H</i>)-dione monohydrate
C11H12N2O2,H2O
Acta Crystallographica Section E (2020) 76, 8 1296-1301
a=7.0695(4)Å b=10.8321(5)Å c=14.4349(6)Å
α=90° β=101.556(3)° γ=90°
2-Chloroethyl 2-oxo-1-(prop-2-yn-1-yl)-1,2-dihydroquinoline-4-carboxylate
C15H12ClNO3
Acta Crystallographica Section E (2019) 75, 10 1411-1417
a=7.1809(2)Å b=21.4466(5)Å c=8.9173(2)Å
α=90° β=92.784(2)° γ=90°
1,3-Dimethyl-3-tetradecyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione
C25H40N2O2
Acta Crystallographica Section E (2011) 67, 3 o674
a=8.12860(10)Å b=33.5899(5)Å c=9.4095(2)Å
α=90.00° β=114.6400(10)° γ=90.00°
3-(6-Bromohexyl)-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione
C17H23BrN2O2
Acta Crystallographica Section E (2010) 66, 11 o2804
a=7.52140(10)Å b=9.3693(2)Å c=23.8686(5)Å
α=90.00° β=91.7500(10)° γ=90.00°
3-(12-Bromododecyl)-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione
C23H35BrN2O2
Acta Crystallographica Section E (2010) 66, 11 o2805
a=7.59710(10)Å b=10.5032(2)Å c=28.7129(5)Å
α=90.00° β=95.2130(10)° γ=90.00°
1-Dodecylindoline-2,3-dione
C20H29NO2
Acta Crystallographica Section E (2014) 70, 2 o229
a=25.2013(7)Å b=4.66818(9)Å c=15.7013(4)Å
α=90.00° β=104.926(3)° γ=90.00°
1-(Prop-2-ynyl)-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C10H8N2O
Acta Crystallographica Section E (2013) 69, 1 o119
a=4.5553(6)Å b=18.001(3)Å c=10.7488(13)Å
α=90.00° β=93.645(8)° γ=90.00°
1-(4-Methylbenzyl)-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C15H14N2O
Acta Crystallographica Section E (2013) 69, 1 o122
a=12.5585(5)Å b=5.7181(2)Å c=17.4153(7)Å
α=90.00° β=95.277(2)° γ=90.00°
1,3-Dibenzyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C21H18N2O
Acta Crystallographica Section E (2011) 67, 12 o3234
a=19.5983(7)Å b=9.0882(2)Å c=10.0473(3)Å
α=90.00° β=115.593(4)° γ=90.00°
5-Chloro-1-nonyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C16H23ClN2O
Acta Crystallographica Section E (2011) 67, 12 o3340-o3341
a=5.51441(17)Å b=15.6507(4)Å c=20.0540(6)Å
α=71.807(3)° β=86.612(2)° γ=80.709(2)°
1-Allyl-1<i>H</i>-1,3-benzimidazol-2(3<i>H</i>)-one
C10H10N2O
Acta Crystallographica Section E (2012) 68, 11 o3212
a=10.2749(5)Å b=5.5787(3)Å c=16.6220(9)Å
α=90.00° β=100.976(4)° γ=90.00°
1-Dodecyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one
C19H30N2O
Acta Crystallographica Section E (2012) 68, 11 o3069
a=38.3223(14)Å b=4.8318(2)Å c=21.9831(8)Å
α=90.00° β=117.843(2)° γ=90.00°
1-(Prop-2-ynyl)indoline-2,3-dione
C11H7NO2
Acta Crystallographica Section E (2014) 70, 3 o360
a=7.0939(7)Å b=7.9452(7)Å c=8.5658(6)Å
α=80.464(7)° β=85.760(7)° γ=63.881(9)°